GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (OTCPK:CASBF) » Definitions » Other Long-Term Liabilities

CASBF (CanSino Biologics) Other Long-Term Liabilities : $22.66 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CanSino Biologics Other Long-Term Liabilities?

CanSino Biologics's other long-term liabilities for the quarter that ended in Dec. 2024 was $22.66 Mil.

CanSino Biologics's quarterly other long-term liabilities declined from Mar. 2024 ($27.32 Mil) to Jun. 2024 ($22.69 Mil) and declined from Jun. 2024 ($22.69 Mil) to Dec. 2024 ($22.66 Mil).

CanSino Biologics's annual other long-term liabilities declined from Dec. 2022 ($29.40 Mil) to Dec. 2023 ($26.64 Mil) and declined from Dec. 2023 ($26.64 Mil) to Dec. 2024 ($22.66 Mil).

CanSino Biologics Other Long-Term Liabilities Historical Data

The historical data trend for CanSino Biologics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Other Long-Term Liabilities Chart

CanSino Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only 26.08 29.60 29.40 26.64 22.66

CanSino Biologics Quarterly Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.63 26.64 27.32 22.69 22.66

CanSino Biologics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

CanSino Biologics Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

CanSino Biologics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (OTCPK:CASBF) » Definitions » Other Long-Term Liabilities
Comparable Companies
HKSE:00570 HKSE:01558 HKSE:02005 HKSE:01681 HKSE:00460 HKSE:02186 HKSE:03613 HKSE:01349 HKSE:02877 HKSE:02561 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
06185:Hong Kong CJH:Germany 688185:China
Address
185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN
Website
https://www.cansinotech.com
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.